Kirin Holdings Company, Limited Sponsored ADR (KNBWY)
Kyowa Kirin stops development of skin condition treatment
Kyowa Kirin on Tuesday said it is discontinuing all ongoing trials of its experimental drug to treat skin conditions.
3 Reasons Growth Investors Will Love Kirin (KNBWY)
Kirin (KNBWY) could produce exceptional returns because of its solid growth attributes.
Kirin (KNBWY) Upgraded to Buy: What Does It Mean for the Stock?
Kirin (KNBWY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Is Kirin (KNBWY) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy Kirin (KNBWY) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Kirin (KNBWY) Stock Outpacing Its Consumer Staples Peers This Year?
Here is how Kirin Holdings Co. (KNBWY) and Service Corp. (SCI) have performed compared to their sector so far this year.
Are Investors Undervaluing Kirin (KNBWY) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Kirin (KNBWY) Outperforming Other Consumer Staples Stocks This Year?
Here is how Kirin Holdings Co. (KNBWY) and US Foods (USFD) have performed compared to their sector so far this year.
Should Value Investors Buy Kirin (KNBWY) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Kirin Holdings: Q1 Performance Had Mixed Takeaways
I remain Neutral on Kirin Holdings, as both positives and negatives emerged from the latest quarterly results. 1Q25 operating income grew by a reasonably strong 10%, but this was helped by non-recurring items. Kirin's domestic beverage segment didn't do as well as its key competitors; but there were improvements with its Oceania beer and health science divisions.
KNBWY vs. BUD: Which Stock Is the Better Value Option?
Investors with an interest in Beverages - Alcohol stocks have likely encountered both Kirin Holdings Co. (KNBWY) and Anheuser-Busch Inbev (BUD). But which of these two stocks is more attractive to value investors?
Are Investors Undervaluing Kirin (KNBWY) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
